Navigation Links
Prize or patent? Innovative ideas for funding medical drug development and access
Date:3/17/2008

The Maastricht Economic and social Research and training centre on Innovation and Technology (UNU-MERIT) and the United Nations University Office in New York (UNU-ONY) are co-organizing a forum on monetary prizes as an alternative to binding patents as a means of encouraging medical drug development.

The objective of the forum Prize or Patent? is to explore whether, and how, prizes could be used to direct pharmacuetical research to more socially beneficial ends. Prizes may be used, for example, to promote research into diseases that primarily effect the poor (malaria, tuberculosis, etc.), or to ensure that drugs, once developed, are freely available and not limited only to those who can afford the high prices charged by patent holders.

Speakers will include:

  • Jamie Love, Director, Knowledge Ecology International (KEI)

  • Kalipso Chalkidou, Associate Director of Research and Development, National Institute for Health and Clinical Excellence (NICE, UK)

  • A.E. Ogwell, Head of International Relations, Ministry of Health, Kenya

  • Dilip Shah, Secretary General, Indian Pharmaceutical Alliance

  • Rishab Aiyer Ghosh, Head, Collaborative Creativity Group, UNU-MERIT

Date, time and place:
March 20 2008, 3:00 pm 5:30 pm
Conference Room 7, UN Headquarters, New york


'/>"/>

Contact: Ken Stretch
ken@ony.unu.edu
212-963-6387
United Nations University
Source:Eurekalert

0

GOOD

Page: 1

Related medicine news :

1. Virginia Beach Man Loses 17 Pounds, on Top of a Previous 100 Pound Loss, and Wins Major $50,000 Prize
2. Whole Planet Foundation(TM) (a Whole Foods Market Foundation) and Nobel Peace Prize Winner Dr. Muhammad Yunus Partner With Natural Foods Vendors, Pledging Over $1 Million to Help Combat Poverty
3. Stanford biologist awarded 2008 Sophie Prize in Norway
4. Chiltern Wins Top Prize
5. Bart De Strooper receives prestigious $200,000 Alzheimer Prize
6. William Jefferson Clinton TED Prize Wish Update
7. Al Gore, Tom Stoppard and Amos Oz Are 2008 Dan David Prize winners
8. PNAS announces 2007 Cozzarelli Prize recipients
9. Worlds best analysts compete to win Edelman Prize in operations research and analytics
10. DuPont Pledges $1 Million to World Food Prize
11. Dr. Inder Verma named recipient of 2008 Vilcek Prize in biomedical science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...c. 2 VirtualScopics, Inc...tative imaging for clinical,trials, today announc...,compared to $14.7 million at the same time a year...lculates backlog as the amount remaining to be,re...ration of the studies,included within the backlog...
(Date:12/2/2008)...ew Report Finds Many Cite Prevention, Shedding, or...2 A New Center for Stat...how states are balancing retiree health care plans...ree Health Care in the American States examines h... retiree health care benefits to central human res...
(Date:12/2/2008)... Patients treated with radiation prior to surger...of cancer recurrence and better overall survival r...The report examined a treatment called neoadjuvant... limit the spread of cancer, before surgery to rem...motherapy and/or radiation. , Neoadjuvant thera...
(Date:12/2/2008)...A new report from the Institute of Medicine propos...workloads to decrease the chances of fatigue-relat...ronment for these doctors in training. The report...rk hours from the maximum average of 80 per week s...al Education (ACGME) in 2003, but rather reduces t...
Breaking Medicine News(10 mins):Health News:VirtualScopics Backlog Rises to a Record $27 Million 2Health News:VirtualScopics Backlog Rises to a Record $27 Million 3Health News:States View Limits on Retiree Health Benefits 2Health News:Revised hours and workloads for medical residents needed to prevent 2Health News:Revised hours and workloads for medical residents needed to prevent 3
...ican Journal of Preventive Medicine says that ther...sease. These conclusions were arrived at by resea...ealth at the Centers for Disease Control and Preve...pondents who took part in the 1999-2002 Behavioral...
...evealed that a version of the Viagra pill meant fo...nction market is much larger when compared to that...o develop a pill for that, according to Ellis. The...an has to be factored in for developing the pill, ...
...ents with psychiatric disorders. The number of pat... by 12% in the past 4 years. This shows us that ...ties. According to the Australian Institute of He... number of patients attending to specialized psych...
...of Camembert cheese with the microorganism E.coli,...d from supply due to potential risk of food poison...ning notice against consumption of this cheese. A...etes a bacterial toxin named verocytotoxins has be...
Other Medicine News:Health News:Community hospitals inundated with Psychiatric care cases (12%) 2
(Date:12/1/2008)...ire/ -- S*BIO Pte Ltd today announced the initiati...nt and orally-active JAK2 inhibitor, in leading me...ic idiopathic myelofibrosis (CIMF). , , Th...erability of SB1518 in patients with CIMF and is e...art of the study will assess the safety profile an...
(Date:12/1/2008)...tasia Treated With ENB-0040 at Children,s Hospital...NTREAL, Dec. 1 Enobia Pharma, an e...ping novel therapeutics for serious bone disorders... its clinical program for hypophosphatasia was dos...rapy (ERT) with ENB-0040 for the treatment of this...
(Date:12/1/2008)...the best policy , , ROCHESTER, Minn., Dec....o Clinic finds the use of the drug therapy etanerc...n acute inflammation of the liver caused by excess...dy are published in the December issue of Gastroe... , VIDEO ALERT: Additional audio and video re...
(Date:12/1/2008)...cember 1 Following a,Re...to procure an MVA-based,third generation smallpo...anada, on behalf of the Canadian Department of Nat... Nordic for the delivery of IMVAMUNE(R). , ... as part of the,country,s bio-preparedness progra...
Breaking Medicine Technology:S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Tumor inhibiting protein could be effective in treating leukemia 4038 1Tumor inhibiting protein could be effective in treating leukemia 4038 2BIO key 28R 29 Issues Open Letter to Shareholders 4036 1BIO key 28R 29 Issues Open Letter to Shareholders 4036 2BIO key 28R 29 Issues Open Letter to Shareholders 4036 3BIO key 28R 29 Issues Open Letter to Shareholders 4036 4BIO key 28R 29 Issues Open Letter to Shareholders 4036 5Incorrectly cleaved protein leads to schizophrenia 6541 1Incorrectly cleaved protein leads to schizophrenia 6541 2Vitalize 28TM 29 Receives Top Multivitamin Rating 23988 1Vitalize 28TM 29 Receives Top Multivitamin Rating 23988 2
Stainless steel construction to withstand sterilization modalities (EtO) Wide angle of view
Inquire
ENDOlap™ laparoscopes provide excellent image linearity and flatness of field.
The Fujinon's R410 laparoscope is the first to bring a 410,000 pixel CCD to the end of the scope. Superior imaging and color replication, along with a unique lens washing capability make the R410 the
Medicine Products: